Get the Stockscreener App
0.26
3.09%
0.0078
After Hours:
.26
Glycomimetics Inc Stock (GLYC) Forecast
The Glycomimetics Inc (GLYC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.6434, representing a +1,686% increase from the current price of $0.26. The highest analyst price target is $4.7165, and the lowest is $4.5703.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GLYC Price Target
Average 5.3842
(+1,971% Upside)
Is Glycomimetics Inc (GLYC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.40 | Neutral |
| STOCH(9,6) | 32.06 | Neutral |
| STOCHRSI(14) | 49.78 | Neutral |
| MACD(12,26) | -0.00549 | Buy |
| ADX(14) | 12.60 | Neutral |
| William %R | -57.99 | Neutral |
| CCI(14) | 3.2366 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2655
Sell
|
0.2583
Buy
|
| MA20 |
0.251
Buy
|
0.2611
Sell
|
| MA50 |
0.3006
Sell
|
0.2701
Sell
|
| MA100 |
0.2454
Buy
|
0.3216
Sell
|
| MA200 |
0.4663
Sell
|
0.6388
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, GLYC could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 7 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on GLYC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 48.4 indicates that GLYC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 32.06 indicates that GLYC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 49.78 indicates that GLYC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 12.6 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 3.2366 indicates that GLYC is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term GLYC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Glycomimetics Inc financial reports and earnings history, Glycomimetics Inc (GLYC) stock could reach $9.1373 by 2030, $9.0243 by 2040 and $26.25 by 2050. See the projected annual prices until 2050 of the Glycomimetics Inc stock below:
- Glycomimetics Inc (GLYC) is expected to reach an average price of $2.9719 in 2035, with a high prediction of $3.5009 and a low estimate of $3.1319. This indicates an $1,043% rise from the last recorded price of $0.26.
- Glycomimetics Inc (GLYC) stock is projected to chart a bullish course in 2040, with an average price target of $8.6328, representing an $3,220% surge from its current level. The forecast ranges from a conservative $8.7076 to a sky-high $9.0243.
- Our analysts predict Glycomimetics Inc (GLYC) to jump 6,386% by 2045, soaring from $16.96 to an average price of $16.86, potentially reaching $17.13. While $16.96 is the low estimate, the potential upside is significant.
- Glycomimetics Inc (GLYC) stock is expected to climb by 2050, reaching an average of $25.84, a $9,839% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.25 and $26.04, respectively, highlighting the market's uncertainty.
Glycomimetics Inc Stock (GLYC) Year by Year Forecast
Glycomimetics Inc Stock (GLYC) Price Forecast for 2025
Glycomimetics Inc Stock (GLYC) is expected to reach an average price of $5.3842 in 2025, with a high prediction of $6.7375 and a low estimate of $4.0308. This indicates an +1,971% rise from the last recorded price of $0.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $5.0165 | $4.5703 | $4.7165 | +1,829% |
| March, 2025 | $5.7314 | $5.0052 | $5.0414 | +2,104% |
| April, 2025 | $6.725 | $5.7601 | $6.7375 | +2,487% |
| May, 2025 | $6.3199 | $6.3649 | $6.7337 | +2,331% |
| June, 2025 | $5.6448 | $5.9048 | $5.9773 | +2,071% |
| July, 2025 | $5.6034 | $5.7935 | $5.611 | +2,055% |
| August, 2025 | $4.4633 | $4.7983 | $5.1371 | +1,617% |
| September, 2025 | $4.4382 | $4.0308 | $4.0744 | +1,607% |
| October, 2025 | $4.8718 | $4.5598 | $4.4844 | +1,774% |
| November, 2025 | $4.9967 | $4.7993 | $4.7567 | +1,822% |
| December, 2025 | $5.1104 | $4.7629 | $4.8155 | +1,866% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2026
The predicted value for Glycomimetics Inc (GLYC) in 2026 is set at an average of $4.134. Estimates vary from a peak of $4.7791 to a trough of $3.489, indicating an +1,490% surge from the present price of $0.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.1253 | $4.2795 | $4.7791 | +1,487% |
| February, 2026 | $4.0702 | $4.1027 | $3.974 | +1,465% |
| March, 2026 | $3.6801 | $3.9151 | $3.6364 | +1,315% |
| April, 2026 | $3.5337 | $3.489 | $3.5538 | +1,259% |
| May, 2026 | $3.8036 | $4.0036 | $3.9449 | +1,363% |
| June, 2026 | $4.2385 | $4.1398 | $4.1411 | +1,530% |
| July, 2026 | $4.5621 | $4.6447 | $4.4634 | +1,655% |
| August, 2026 | $4.097 | $4.317 | $4.3096 | +1,476% |
| September, 2026 | $4.4507 | $4.4719 | $4.4007 | +1,612% |
| October, 2026 | $4.5056 | $4.6068 | $4.4368 | +1,633% |
| November, 2026 | $4.2205 | $4.4405 | $4.533 | +1,523% |
| December, 2026 | $4.0941 | $4.0941 | $4.0292 | +1,475% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Glycomimetics Inc (GLYC) is $4.1688, with a high forecast of $4.4799 and a low forecast of $3.8578. This indicates an +1,503% increase from the last price of $0.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.199 | $4.1728 | $4.169 | +1,515% |
| February, 2027 | $4.1539 | $4.1322 | $4.1677 | +1,498% |
| March, 2027 | $4.2675 | $4.2826 | $4.2375 | +1,541% |
| April, 2027 | $4.5124 | $4.3112 | $4.3324 | +1,636% |
| May, 2027 | $4.5473 | $4.5486 | $4.4799 | +1,649% |
| June, 2027 | $4.4009 | $4.3122 | $4.446 | +1,593% |
| July, 2027 | $4.2058 | $4.2171 | $4.2697 | +1,518% |
| August, 2027 | $4.3109 | $4.1846 | $4.2025 | +1,558% |
| September, 2027 | $4.4328 | $4.4895 | $4.4507 | +1,605% |
| October, 2027 | $4.3219 | $4.3506 | $4.3531 | +1,562% |
| November, 2027 | $4.162 | $4.2827 | $4.2552 | +1,501% |
| December, 2027 | $3.7781 | $3.8578 | $4.1129 | +1,353% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2028
In 2028, Glycomimetics Inc (GLYC) is projected to reach an average price of $2.2742, with a high projection of $3.7589 and a low estimate of $0.7896. This indicates an +774.71% rise from the last price of $0.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.7973 | $3.7852 | $3.7427 | +1,361% |
| February, 2028 | $3.8559 | $3.8088 | $3.7589 | +1,383% |
| March, 2028 | $3.5729 | $3.5912 | $3.6963 | +1,274% |
| April, 2028 | $2.0761 | $2.3161 | $3.475 | +698.51% |
| May, 2028 | $1.6998 | $1.8598 | $1.8949 | +553.75% |
| June, 2028 | $1.2847 | $1.1559 | $0.7748 | +394.10% |
| July, 2028 | $0.2396 | $0.7896 | $0.6308 | -7.86% |
| August, 2028 | $2.2532 | $1.987 | $1.9532 | +766.61% |
| September, 2028 | $2.1681 | $2.1506 | $2.1481 | +733.88% |
| October, 2028 | $1.783 | $1.9565 | $1.8943 | +585.77% |
| November, 2028 | $1.2566 | $1.3066 | $1.2479 | +383.32% |
| December, 2028 | $1.2915 | $1.3128 | $1.1229 | +396.74% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2029
The 2029 price forecast for Glycomimetics Inc Stock (GLYC) is $4.0211 on average, with a high prediction of $8.00 and a low estimate of $0.0422. This represents an +1,447% increase from the previous price of $0.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.2351 | $1.2651 | $1.2602 | +375.06% |
| February, 2029 | $1.10 | $1.19 | $1.1839 | +323.10% |
| March, 2029 | $1.215 | $1.1275 | $1.12 | +367.29% |
| April, 2029 | $1.0799 | $1.1711 | $1.1137 | +315.33% |
| May, 2029 | $1.1435 | $1.1448 | $1.1673 | +339.80% |
| June, 2029 | $0.4984 | $0.6184 | $0.8422 | +91.68% |
| July, 2029 | $0.2667 | $0.2046 | $0.6667 | +2.58% |
| August, 2029 | $1.0631 | $0.138 | $1.5631 | +308.88% |
| September, 2029 | $1.0882 | $0.8144 | $1.5482 | +318.54% |
| October, 2029 | $1.2746 | $0.8133 | $1.4846 | +390.22% |
| November, 2029 | $0.3947 | $0.3497 | $1.5671 | +51.79% |
| December, 2029 | $8.98 | $0.0422 | $8.00 | +3,354% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2030
Glycomimetics Inc Stock (GLYC) is expected to reach an average price of $12.87 in 2030, with a high forecast of $16.86 and a low forecast of $8.8871. This signifies an +4,852% surge from the last price of $0.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.6273 | $9.4248 | $9.1373 | +3,603% |
| February, 2030 | $7.8471 | $8.8871 | $8.9247 | +2,918% |
| March, 2030 | $11.26 | $9.4445 | $11.13 | +4,230% |
| April, 2030 | $16.82 | $16.93 | $16.86 | +6,370% |
| May, 2030 | $15.49 | $15.52 | $16.32 | +5,859% |
| June, 2030 | $14.44 | $14.87 | $15.30 | +5,455% |
| July, 2030 | $14.30 | $13.48 | $13.85 | +5,400% |
| August, 2030 | $13.50 | $13.48 | $13.19 | +5,093% |
| September, 2030 | $13.90 | $13.52 | $13.29 | +5,246% |
| October, 2030 | $14.21 | $14.06 | $14.00 | +5,366% |
| November, 2030 | $15.68 | $14.39 | $14.77 | +5,932% |
| December, 2030 | $15.85 | $15.83 | $15.81 | +5,995% |
0.65%
4.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):